OPKO Health, Inc. (NASDAQ:OPK) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET
Company Participants
Yvonne Briggs – Alliance Advisors IR
Dr. Phillip Frost – Chairman and CEO
Dr. Elias Zerhouni – Vice Chairman and President
Adam Logal – Chief Financial Officer
Gary Nabel – Chief Innovation Officer
Conference Call Participants
Maury Raycroft – Jefferies
Yi Chen – H. C. Wainwright & Co., LLC
Jeffrey Cohen – Ladenburg Thalmann
Edward Tenthoff – Piper Sandler
Yale Jen – Laidlaw and Company
Michael Petusky – Barrington Research
Operator
Good afternoon, and welcome to the OPKO Health First Quarter 2025 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Yvonne Briggs. Please go ahead.
Yvonne Briggs
Thank you, operator. Good afternoon. This is Yvonne Briggs with Alliance Advisors IR. Thank you all for joining today’s call to discuss OPKO Health’s financial results for the first quarter of 2025.
I’d like to remind you that any statements made during this call by management other than statements of historical fact will be considered forward-looking, and as such, will be subject to risks and uncertainties that could materially affect the company’s expected results. These forward-looking statements include, without limitation, the various risks described in the company’s SEC filings, including the annual report on Form 10-K for the year ended December 31, 2024, and subsequently filed SEC reports.
Furthermore, this conference call contains time-sensitive information that is accurate only as of the date of the live broadcast, on April 30, 2025. Except as required by law, OPKO undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date
Read the full article here